James E Dentzer insider trades

Open-market stock purchases and sales by James E Dentzer, President & CEO at Curis Inc, from SEC Form 4 filings since Feb 14, 2014.

Recent trades

DateStockTradeValue
Jul 7, 2026CRIS Curis IncBought (not open market)$582K
May 22, 2026IMNN Imunon, IncBought (not open market)$24.5K
Mar 20, 2026CRIS Curis IncBought (not open market)—
Mar 20, 2026CRIS Curis IncBought (not open market)—
Mar 17, 2026CRIS Curis IncBought (not open market)—
Mar 17, 2026CRIS Curis IncBought (not open market)$100K
Jan 2, 2026IMNN Imunon, IncBought (not open market)—

Companies traded

  • CRIS Curis Inc: 8 sales, last Jul 7, 2026
  • IMNN Imunon, Inc: other filings, last May 22, 2026
  • DRNA Dicerna Pharmaceuticals Inc: other filings, last Jan 9, 2015

Get free alerts when James E Dentzer files a new trade →